Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Depreciation & Amortization (CF) (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $804000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 11.36% year-over-year to $804000.0, compared with a TTM value of $3.4 million through Dec 2025, down 12.73%, and an annual FY2025 reading of $3.4 million, down 12.73% over the prior year.
  • Depreciation & Amortization (CF) was $804000.0 for Q4 2025 at Wave Life Sciences, down from $856000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.9 million in Q1 2021 and bottomed at $804000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $1.3 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) dropped 4.46% in 2021, then fell 28.51% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $1.8 million in 2021, then fell by 15.01% to $1.5 million in 2022, then dropped by 28.51% to $1.1 million in 2023, then decreased by 16.1% to $907000.0 in 2024, then fell by 11.36% to $804000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for WVE at $804000.0 in Q4 2025, $856000.0 in Q3 2025, and $865000.0 in Q2 2025.